Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 626.00
Bid: 622.00
Ask: 628.00
Change: 4.00 (0.64%)
Spread: 6.00 (0.965%)
Open: 630.00
High: 638.00
Low: 624.00
Prev. Close: 622.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury playwright Jon Fosse wins Nobel Prize

9 Oct 2023 13:00

RNS Number : 4421P
Bloomsbury Publishing PLC
09 October 2023
 

 

Bloomsbury playwright Jon Fosse wins Nobel Prize in Literature

 

 

9 October, LONDON: Bloomsbury, the leading independent publisher, is pleased to announce that its author Jon Fosse, the Norwegian playwright, has won the 2023 Nobel Prize in literature "for his innovative plays and prose which give voice to the unsayable."

 

According to the citation of the Nobel committee, "his immense oeuvre, written in Norwegian Nynorsk and spanning a variety of genres consists of a wealth of plays, novels, poetry collections, essays, children's books and translations. While he is today one of the most widely performed playwrights in the world, he has also become increasingly recognised for his prose."

 

Jon Fosse has won many European awards and in 2007 he was made a Knight in France's National Order of Merit. He has written 40 plays, performed around the world in different languages, including the Septology series of novels, Aliss at the Fire, Melancholy and A Shining.

 

Winning the 2023 Nobel Prize for Literature, Jon Fosse becomes the 8th Nobel-Prize winning writer from Bloomsbury's imprint Methuen Drama, joining Peter Handke, Dario Fo, Toni Morrison, Wole Soyinka, Luigi Pirandello, John Galsworthy and George Bernard Shaw.

 

Fosse's first English language play collection was published by Oberon Books, acquired by Bloomsbury in 2019, which has now published six collections of his plays, alongside single playtexts including I Am The Wind and The Dead Dogs to coincide with major premiere productions in London.

 

Nigel Newton, Chief Executive of Bloomsbury, commented: "Jon Fosse's remarkable body of dramatic work was fiercely championed by Oberon Books, now part of Methuen Drama, within the Bloomsbury Academic division, since the publication of his first English language play collection in 2002. Since then, we have published five further anthologies, totalling over 30 plays and a number of standalone translations and adaptations by some of the world's most successful contemporary dramatists. While he is one of the most-performed writers in Europe, his dramatic canon is less well-known on U.K. stages and we hope that with this historic win, the English speaking theatre community will discover and fall for his unique linguistic style, poetic naturalism and formally inventive work that manages to be both existential and life-affirming."

 

 

-ENDS-

 

For further information please contact:

 

Hudson Sandler

 

+44 (0) 20 7796 4133

Dan de Belder/Emily Brooker

 

bloomsbury@hudsonsandler.com

 

 

Bloomsbury Publishing Plc

Bloomsbury is a leading independent publisher of fiction, non-fiction, children's, specialist, academic and professional titles, listed on the London Stock Exchange. It is one of the few publishers with a portfolio that includes both general and academic publishing. Bloomsbury's ambitious growth story has seen the Group become a significant global publisher with offices in the UK, US, Australia and India.

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGUWUUPWGGB
Date   Source Headline
20th Jul 20177:00 amRNSDirector/PDMR Shareholding
18th Jul 20171:19 pmRNSResults of voting on resolutions at the AGM
18th Jul 20177:00 amRNSTrading Statement
4th Jul 20172:45 pmRNSDirector/PDMR Shareholding
19th Jun 20179:55 amRNSAnnual Financial Report
16th Jun 20177:00 amRNSBoard Appointment
19th May 20174:44 pmRNS6 Month Blocklisting Return
18th May 20177:00 amRNSFinal Results
23rd Mar 20171:47 pmRNSHolding(s) in Company
20th Jan 20177:00 amRNSBoard Appointment
4th Jan 20177:15 amRNSEmployee Benefit Trust purchase of shares
13th Dec 20164:53 pmRNSDirector/PDMR Shareholding
13th Dec 20164:52 pmRNSDirector/PDMR Shareholding
13th Dec 20164:50 pmRNSDirector/PDMR Shareholding
13th Dec 20164:46 pmRNSDirector/PDMR Shareholding
18th Nov 201610:35 amRNSBlock Listing Six Monthly Return
1st Nov 20164:08 pmRNSHolding(s) in Company
1st Nov 20162:58 pmRNSHolding(s) in Company
27th Oct 20167:00 amRNSHalf-year Report
4th Oct 20164:35 pmRNSPrice Monitoring Extension
12th Sep 20164:30 pmRNSPro forma historic results
31st Aug 20163:09 pmRNSTotal Voting Rights
23rd Aug 20162:14 pmRNSApplication for Admission
16th Aug 20169:55 amRNSHolding(s) in Company
19th Jul 20161:24 pmRNSResults of voting on resolutions at the AGM
18th Jul 20163:15 pmRNSHolding(s) in Company
13th Jul 20167:00 amRNSCapital Markets Day and Business Update
4th Jul 20165:31 pmRNSHolding(s) in Company
24th Jun 20162:43 pmRNSAnnual Financial Report
9th Jun 201612:43 pmRNSDirector/PDMR Shareholding
9th Jun 201612:41 pmRNSDirector/PDMR Shareholding
9th Jun 201612:41 pmRNSDirector/PDMR Shareholding
9th Jun 201612:39 pmRNSDirector/PDMR Shareholding
27th May 20162:21 pmRNSEmployee Benefit Trust purchase of shares
24th May 20164:35 pmRNSEmployee Benefit Trust purchase of shares
23rd May 201611:14 amRNSBlock Listing Six Monthly Return
19th May 20167:00 amRNSPreliminary Results
19th Apr 20163:19 pmRNSHolding(s) in Company
15th Apr 20164:22 pmRNSHolding(s) in Company
15th Apr 20164:09 pmRNSHolding(s) in Company
19th Feb 20162:12 pmRNSHolding(s) in Company
29th Jan 20166:28 pmRNSTotal Voting Rights
22nd Jan 20163:02 pmRNSCompletion of Acquisition
18th Jan 201612:20 pmRNSDirector/PDMR Shareholding
18th Jan 201612:19 pmRNSDirector/PDMR Shareholding
18th Jan 201612:17 pmRNSDirector/PDMR Shareholding
18th Jan 201612:16 pmRNSDirector/PDMR Shareholding
21st Dec 20155:35 pmRNSAcquisition
18th Nov 20155:23 pmRNSBlock Listing Six Monthly Return
27th Oct 20157:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.